Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell ...
Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, announced today that it has received a Notice of Allowance ...
Avalon granted Notice of Allowance for CAR-T and CAR-NK cell technology in China
GloboCare has received a Notice of Allowance from the China National Intellectual Property Administration for its patent ...